Daewoong has officially launched its flagship botulinum toxin product, NABOTA, and a comprehensive K-Beauty aesthetic solution in the Indonesian market.
On July 19, the company held the “CGBIO Launch Symposium – MOVE TO NEW GEN” at the Ranggam Hotel in Jakarta, where it unveiled five key aesthetic products, including NABOTA, DCLASSY HA, DCLASSY CaHA, LUXX, and DOOTH.
This launch goes beyond simple product supply; it emphasizes sharing practical, clinically applicable multi-procedure techniques. Around 100 dermatology and aesthetic medicine professionals participated, engaging in hands-on sessions based on clinical experience. This initiative aims to enable more sophisticated and satisfying aesthetic medical services locally.
Multi-procedure treatments require precise coordination of procedures and medications, demanding skilled clinical expertise. Based on its proven experience and advanced technologies, Daewoong plans to provide integrated product and procedure guidance tailored to the Indonesian market.
During the symposium, Dr. Yoon Choon-sik of Yemiwon Skin Clinic highlighted NABOTA’s high purity and proven stability, noting its minimal immune reactions and consistent results. He also introduced Daewoong’s proprietary combined procedure, ‘Naborift,’ which targets skin and muscle layers simultaneously, offering combined lifting, wrinkle reduction, and skin texture improvement.
The event also featured international experts from Indonesia and Europe. Dr. Inek Jane from Youth & Beauty Clinic remarked, “NABOTA’s quick response and natural-looking results were impressive,” while Dr. Ervan Montiya of Dorsia Clinic in Portugal praised the combined use of DCLASSY HA and CaHA, citing their smooth injection feel and excellent skin tightening effects.
DCLASSY, Daewoong’s premium aesthetic brand, is scheduled for official launch in Indonesia in the second half of 2025. It features three types of hyaluronic acid (HA) fillers—SOFT, INTENSE, and VOLUME—for precise treatments. Its CaHA formulation employs patented spherical particles that promote collagen production for natural lifting effects.
Additionally, to meet growing demand for non-invasive cosmetic procedures, Daewoong plans to introduce SILIFTING products LUXX and DOOTH in Indonesia by 2025.
This symposium was organized by KIIMOT (Korea-Indonesia Integrated Marketing Operation Taskforce), a joint organization operated by Daewoong and DNC Aesthetic. KIIMOT aims to transfer Daewoong’s treatment expertise to Indonesian medical professionals and foster an educational ecosystem where treatment protocols and products evolve together. Strengthening the educational framework through Daewoong’s ‘DEEP’ (Daewoong-DNC Medical-Aesthetic Expert Program) aims to connect Korean and Indonesian medical expertise.
Hah Chang-woo, head of KIIMOT, stated, “Indonesia is a strategic market with high demand for medical aesthetics and great interest in K-Beauty. Based on Daewoong’s world-class products and multi-procedure techniques, we will nurture local professionals and establish Korean-style aesthetic solutions in Indonesia.”
